<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03685955</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00168089</org_study_id>
    <nct_id>NCT03685955</nct_id>
  </id_info>
  <brief_title>Efficacy of Amniotic Membranes in Complex Genitourinary Reconstruction</brief_title>
  <official_title>The Effect of Amniotic Membranes on Complex Genitourinary Reconstruction Outcomes in Pediatric and Adult Populations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urinary fistulas are unfortunately one of the most common post operative complications in
      hypospadias repairs and bladder neck transections on pediatric and adult populations, an
      estimated 20%, resulting in multiple repeat operations with prolonged hospitalization. The
      negative sequelae of these fistulas have significant financial and psychosocial impact and
      the aim of this study is to evaluate if the fresh frozen preserved amniotic membrane tissue
      studied, which have live cells and intact naturally occurring growth hormones and peptides
      that augment healing that have been shown in early studies to be effective facilitating
      previous failed fistula repairs and leg ulcer healing, respectively, will help reduce the
      incidence of urinary fistulas in subject populations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Urinary fistulas in the pediatric and adult populations present significant surgical and
      economical challenges. These include urethrocutaneous and vesicocutaneous fistulas, which are
      unfortunately common in the investigators' patients with hypospadias and bladder exstrophy,
      respectively. Urethrocutaneous fistula is the most common complication following surgical
      repair of hypospadias with an incidence of 4-25%. This high complication rate is especially
      problematic as these fistulas once formed often recur requiring multiple surgical repairs
      resulting in potentially harmful physical and psychologic consequences on young patients.
      Vesicocutaneous fistulas develop in bladder exstrophy patients at a estimated rate of 20%
      following surgery aimed at making these patients continent by transecting the bladder neck
      and creating a catheterizable channel. Small, simple fistulas can be repaired primarily,
      however larger, multiple or recurrent fistulas must be closed in layers. Layered closures
      have been found to have higher success rates have been demonstrated with using additional
      tissue layers refistulization rate including local and distant tissue grafts, which add time
      and morbidity to surgical repairs.

      Amniotic membranes have been shown to increase healing in chronic wounds such as a chronic
      venous stasis and diabetic ulcers and have been used in fistula repairs. Grafix and Stravix
      are frozen preserved placental membranes and Wharton's Jelly, respectively, that have high
      quantities of viable mesenchymal stem cells (MSCs), which add in tissue healing. The
      investigators believe these membranes can be used as a structural layer in fistula repairs,
      hypospadias repairs, and bladder neck closures to treat existing fistulas and prevent fistula
      formation in the primary repair setting.

        1. This is a prospective study examining patients with hypospadias will be considered for
           repair with the use of amniotic membranes. The repair of fistula with graft tissue is
           standard of care.

        2. Eligible patients will be identified in a clinic visit with one of the co-investigators.

           a. The patient will be consented and undergo a repair using amniotic membranes within
           the fistula site or primary repair at the discretion of the operating surgeon. Using
           different repair techniques is standard of care, however, the use of frozen preserved
           placental membranes is the study material. The size of the product will be determined by
           the surgical need at the time of repair.

        3. The patient will be discharged be provided with routine postoperative care and seen in
           approximately 2 weeks per standard of are.

        4. If the participant fails repair of participant's fistula, participant will not be
           offered a repeat repair with the amniotic membranes. Other forms of surgery may be
           offered, however.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Lack of supporting staff
  </why_stopped>
  <start_date type="Anticipated">March 2020</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Failure rate of complex genitourinary reconstruction after incorporation of placental membranes into repair.</measure>
    <time_frame>2 years</time_frame>
    <description>We will evaluate patients with complex genitourinary wounds who have undergone surgical repair using preserved placental membranes, Grafix or Stravix. They will be evaluated in the standard post operative fashion to evaluate for failure of surgical repair of complex genitourinary reconstruction which will be defined by stricture recurrence, wound dehiscence, or recurrence of fistula.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Hypospadias</condition>
  <condition>Hypospadias and Epispadias and Other Penile Anomalies</condition>
  <condition>Fistula</condition>
  <condition>Fistula, Urinary</condition>
  <condition>Bladder Exstrophy and Epispadias Complex</condition>
  <condition>Bladder and Bladder Neck Disorders (Excluding Calculi)</condition>
  <arm_group>
    <arm_group_label>Genitourinary Reconstruction with Amniotic Membranes</arm_group_label>
    <description>Patients who undergo genitourinary reconstruction with amniotic membranes</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Amniotic membranes</intervention_name>
    <description>Amniotic membranes will be employed during participant's genitourinary reconstruction</description>
    <arm_group_label>Genitourinary Reconstruction with Amniotic Membranes</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric and adult populations with complex genitourinary reconstructive needs including
        pediatric hypospadias repair, bladder exstrophy, neurogenic bladder, urinary fistulas,
        urethral stricture disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6mo - 99 years old

          -  Undergoing surgical procedure with risk of or known urinary fistula

        Exclusion Criteria:

          -  Failed prior repair with amniotic membranes

          -  Sensitivity to cryopreservation fluids or disinfecting solutions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heather DiCarlo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Johns Hopkins School of Medicine</affiliation>
  </overall_official>
  <reference>
    <citation>Frykberg RG, Gibbons GW, Walters JL, Wukich DK, Milstein FC. A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane. Int Wound J. 2017 Jun;14(3):569-577. doi: 10.1111/iwj.12649. Epub 2016 Aug 3.</citation>
    <PMID>27489115</PMID>
  </reference>
  <reference>
    <citation>Suzuki K, Michael G, Tamire Y. Viable intact cryopreserved human placental membrane for a non-surgical approach to closure in complex wounds. J Wound Care. 2016 Oct 1;25(Sup10):S25-S31. doi: 10.12968/jowc.2016.25.Sup10.S25.</citation>
    <PMID>27681807</PMID>
  </reference>
  <reference>
    <citation>Duan-Arnold Y, Gyurdieva A, Johnson A, Uveges TE, Jacobstein DA, Danilkovitch A. Retention of Endogenous Viable Cells Enhances the Anti-Inflammatory Activity of Cryopreserved Amnion. Adv Wound Care (New Rochelle). 2015 Sep 1;4(9):523-533.</citation>
    <PMID>26401419</PMID>
  </reference>
  <reference>
    <citation>Cooke M, Tan EK, Mandrycky C, He H, O'Connell J, Tseng SC. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissue. J Wound Care. 2014 Oct;23(10):465-74, 476. doi: 10.12968/jowc.2014.23.10.465.</citation>
    <PMID>25296347</PMID>
  </reference>
  <reference>
    <citation>Batsali AK, Kastrinaki MC, Papadaki HA, Pontikoglou C. Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Curr Stem Cell Res Ther. 2013 Mar;8(2):144-55. Review.</citation>
    <PMID>23279098</PMID>
  </reference>
  <reference>
    <citation>Johnson EL, Tassis EK, Michael GM, Whittinghill SG. Viable placental allograft as a biological dressing in the clinical management of full-thickness thermal occupational burns: Two case reports. Medicine (Baltimore). 2017 Dec;96(49):e9045. doi: 10.1097/MD.0000000000009045.</citation>
    <PMID>29245303</PMID>
  </reference>
  <results_reference>
    <citation>Lavery LA, Fulmer J, Shebetka KA, Regulski M, Vayser D, Fried D, Kashefsky H, Owings TM, Nadarajah J; Grafix Diabetic Foot Ulcer Study Group. The efficacy and safety of Grafix(Â®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial. Int Wound J. 2014 Oct;11(5):554-60. doi: 10.1111/iwj.12329. Epub 2014 Jul 21.</citation>
    <PMID>25048468</PMID>
  </results_reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2018</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypospadias</mesh_term>
    <mesh_term>Bladder Exstrophy</mesh_term>
    <mesh_term>Epispadias</mesh_term>
    <mesh_term>Urinary Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

